Pharmacokinetics CRO

Pharmacokinetics CRO

We conduct in vivo pharmacology studies to assess the efficacy of novel drugs. We utilize a range of animal models to investigate the intricacies of drug effects, dose-response relationships, and the significance of pharmacodynamics in evaluating drug efficacy. Through rigorous testing, we provide valuable insights into drug performance, helping you make informed decisions during the drug development process.

Contact us for more information about our pharmacokinetics CRO services:

Comprehensive Pharmacokinetics CRO Services

Understanding the intricate processes of drug absorption, distribution, metabolism, and excretion is crucial for successful drug development. At Anilocus, we specialize in providing cutting-edge pharmacokinetics research services using animal models, enabling pharmaceutical Sponsors valuable insights into these fundamental aspects of drug behavior for their novel therapeutic.

Our services encompass a wide range of pharmacokinetic parameters, ensuring a comprehensive understanding of drug performance and safety. We offer the following services:

Evaluate the rate and extent of drug absorption using validated animal models, shedding light on factors influencing bioavailability and optimizing therapeutic outcomes.

Investigate how drugs are distributed within the body, determining important parameters such as clearance, volume of distribution, and receptor binding interactions.

Uncover the metabolic fate of drugs in animal models, identifying potential drug-drug interactions and guiding dose adjustment strategies.

Assess the elimination pathways of drugs, ensuring a comprehensive understanding of their clearance mechanisms and aiding in the assessment of safety and therapeutic index.

Utilize advanced mathematical models to simulate and predict drug behavior, facilitating dose optimization, and enabling informed decision-making in drug development.

Additional Services

In addition to our core services, we also provide expertise for in vivo assessment of drug transporters in pharmacokinetics, drug-target interactions, therapeutic drug monitoring, and toxicology studies in animal models. Our comprehensive approach allows us to offer tailored solutions that are adaptable to your specific research needs.

We are committed to delivering reliable pharmacokinetic profiling and analysis to accelerate your drug development process. Partner with us today and harness the power of animal models to unlock new therapeutic possibilities.

Contact us today to revolutionize your pharmacokinetic results.

Regulatory Compliance

GLP; non-GLP

Study Purpose

Drug Safety

Study Duration

Weeks to Months

Animal Species

Mouse, Rat

Est. Research Budget